Evidence map›Paper›PMID 31807884›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2020

Quantitative [

Yiu Ming Khor, Sarah Cuddy, Hendrik J Harms, Marie F Kijewski, Mi-Ae Park, Matthew Robertson, Hyewon Hyun, Marcelo F Di Carli, Giada Bianchi, Heather Landau and 7 more

Open access · greenAbstract read
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Preclinical and preliminary clinical evaluation of [European journal of nuclear medicine and molecular imaging · 2026
    Trial
  2. JACC. Advances · 2026
    Article
  3. Diffuse uptake in the subcutaneous tissue onEuropean journal of nuclear medicine and molecular imaging · 2026
    Article
  4. Review
  5. Prognostic Value of Left VentricularJACC. Cardiovascular imaging · 2024
    Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Diagnosing cardiac amyloidosis in every-day practice: A practical guide for the cardiologist.International journal of cardiology. Heart & vasculature · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 1 country.

Yiu Ming KhorDivision of Nuclear Medicine, Department of Radiology, Brigham and Women's Hospital, Boston, MA, USA.ORCID 0000-0002-4307-1349
Sarah CuddyCardiac Amyloidosis Program, Division of Cardiology, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Hendrik J HarmsDivision of Nuclear Medicine, Department of Radiology, Brigham and Women's Hospital, Boston, MA, USA.
Marie F KijewskiDivision of Nuclear Medicine, Department of Radiology, Brigham and Women's Hospital, Boston, MA, USA.
Mi-Ae ParkDivision of Nuclear Medicine, Department of Radiology, Brigham and Women's Hospital, Boston, MA, USA.
Matthew RobertsonDivision of Nuclear Medicine, Department of Radiology, Brigham and Women's Hospital, Boston, MA, USA.
Hyewon HyunDivision of Nuclear Medicine, Department of Radiology, Brigham and Women's Hospital, Boston, MA, USA.
Marcelo F Di CarliDivision of Nuclear Medicine, Department of Radiology, Brigham and Women's Hospital, Boston, MA, USA.
Giada BianchiDivision of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA.
Heather LandauDivision of Medical Oncology, Memorial Sloan Kettering Medical Center, New York, NY, USA.
Andrew YeeDivision of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
Vaishali SanchorawalaAmyloidosis Center, Boston University School of Medicine, Boston, MA, USA.
Frederick L RubergAmyloidosis Center, Boston University School of Medicine, Boston, MA, USA.
Ronglih LiaoStanford University Cardiovascular Institute and Cardiovascular Medicine, Stanford Amyloid Center, Stanford, CA, USA.
John BerkAmyloidosis Center, Boston University School of Medicine, Boston, MA, USA.
Rodney H FalkCardiac Amyloidosis Program, Division of Cardiology, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Sharmila DorbalaDivision of Nuclear Medicine, Department of Radiology, Brigham and Women's Hospital, Boston, MA, USA. sdorbala@bwh.harvard.edu.
Brigham and Women's Hospital · USBoston University · USCardiovascular Institute of the South · USDana-Farber Cancer Institute · USMassachusetts General Hospital · USMemorial Sloan Kettering Cancer Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Molecular Imaging of Primary Amyloid CardiomyopathyR01HL130563 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI DORBALA, SHARMILA, FALK, RODNEY H · 2016 to 2019
$3.3M
NCI NIH HHS P30 CA008748NHLBI NIH HHS R01 HL130563
6 · The paper itself

Abstract

purposeThe clinical diagnosis of pulmonary involvement in individuals with systemic AL amyloidosis remains challenging. [

methodsWe prospectively enrolled 58 subjects with biopsy-proven AL amyloidosis and 9 control subjects (5 without amyloidosis and 4 with ATTR cardiac amyloidosis). Pulmonary [

resultsOn visual analysis, pulmonary tracer uptake was absent in most AL subjects (40/58, 69%); 12% (7/58) of AL subjects demonstrated intense bilateral homogeneous tracer uptake. In this group, compared to the control group, Vs (median Vs 30-fold higher, 9.79 vs. 0.26, p < 0.001), TBR (median TBR 12.0 vs. 1.71, p < 0.001), and RI (median RI 0.310 vs. 0.033, p < 0.001) were substantially higher. Notably, the AL group without visually apparent pulmonary [

conclusions[

Indexed as

Immunoglobulin Light-chain AmyloidosisPositron Emission Tomography Computed TomographyAniline CompoundsEthylene GlycolsHumansLungAniline CompoundsEthylene Glycolsflorbetapir[18F]florbetapirALLungPET/CTQuantitativeSystemic light chain amyloidosis

Identifiers

PMID31807884
PMCPMC8202062
OpenAlexW2994164822

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.